Updated May 2026 · SEC EDGAR data
Pfizer Inc., Q1 2026 Earnings
Healthcare · Period ending 2026-03-31
Pfizer Inc. (PFE) reported Q1 2026 earnings to the SEC: revenue of $14.5B, EPS of $0.47, and net income of $2.7B. Revenue moved 5.4 percent year-over-year. Sourced directly from Pfizer Inc.'s SEC EDGAR XBRL filings. Sector: Healthcare.
Headline Numbers
Q1 2026 in Context
Pfizer Inc. posted Q1 2026 revenue up 5.4 percent year-over-year, healthy growth in line with strong large-cap performance. Operators selling into this customer should see steady demand.
That works out to a 18.6 percent net margin, strong profitability by any large-cap standard.
The NEUTRAL Operator Read
Across the 8 quarters tracked, Pfizer Inc. carries an operator signal of NEUTRAL with high confidence. Recent quarters are roughly flat; management commentary is steady-state. No major directional signal for operators in adjacent markets.
How This Data Was Sourced
All numbers on this page come directly from Pfizer Inc.'s SEC EDGAR filing for Q1 2026. EDGAR is the U.S. Securities and Exchange Commission's public filing system; quarterly results are filed on Form 10-Q and annual results on Form 10-K. XBRL tagging ensures revenue means revenue across every filer. The earnings press release is typically furnished as a Form 8-K. Both forms are public domain. Read the methodology for the operator-signal classification rules.
Frequently Asked Questions
What did Pfizer Inc. report in Q1 2026?
Pfizer Inc. reported revenue of $14.5B, EPS of $0.47, and net income of $2.7B for Q1 2026. Revenue rose 5.4 percent year-over-year. Figures come from the company's SEC EDGAR XBRL filing.
Where does this earnings data come from?
All numbers on this page are pulled directly from Pfizer Inc.'s SEC EDGAR XBRL filing for Q1 2026 (Form 10-Q for quarterly results, Form 10-K for annual). EDGAR is the SEC's public filing system; XBRL is a structured tagging standard that ensures revenue means revenue across every filer. Data is in the public domain.
What is Pfizer Inc.'s current operator signal?
Pfizer Inc. currently carries a NEUTRAL operator signal with HIGH confidence. The signal is calculated across all available quarters, not just this one, and combines a quantitative read of revenue trajectory with a qualitative read of management commentary. Read the methodology page for the formal classification rules.
Is this earnings analysis investment advice?
No. EarningsCallAI is built for business operators evaluating market trends, demand signals, and competitive dynamics, not for stock trading decisions. Operator signals are not buy/sell recommendations. Always consult a licensed financial advisor before making investment decisions.
When was the Q1 2026 report filed?
Pfizer Inc. filed its Q1 2026 results to the SEC for the period ending 2026-03-31. Quarterly filings (10-Q) are typically due within 40 days of period end for large accelerated filers; annual reports (10-K) are typically due within 60 days.
Pfizer Inc. (PFE) reported Q1 2026 earnings to the SEC: revenue of $14.5B, EPS of $0.47, and net income of $2.7B. Revenue moved 5.4 percent year-over-year. Sourced directly from Pfizer Inc.'s SEC EDGAR XBRL filings. Sector: Healthcare.